Standout Papers

The Cochrane Collaboration's tool for assessing risk... 1999 2026 2008 2017 25.4k
  1. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)
    Julian P. T. Higgins, Doug Altman et al. BMJ
  2. Assessing the quality of controlled clinical trials (2001)
    Peter Jüni et al. BMJ
  3. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study (2008)
    Lesley Wood, Matthias Egger et al. BMJ
  4. The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis (1999)
    Peter Jüni JAMA
  5. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study (2007)
    Joost Daemen, Peter Wenaweser et al. The Lancet
  6. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study (2003)
    Matthias Egger, Peter Jüni et al. Health Technology Assessment
  7. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis (2011)
    Sven Trelle, Stephan Reichenbach et al. BMJ
  8. Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials (2012)
    Jelena Savović, Hayley E Jones et al. Annals of Internal Medicine
  9. Direction and impact of language bias in meta-analyses of controlled trials: empirical study (2002)
    Peter Jüni, Jonathan A C Sterne et al. International Journal of Epidemiology
  10. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis (2004)
    Peter Jüni, Linda Nartey et al. The Lancet
  11. Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism (2013)
    Bernhard Meier, Bindu Kalesan et al. New England Journal of Medicine
  12. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. (2012)
    Jelena Savović, Hayley E Jones et al. Health Technology Assessment
  13. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study (2011)
    Eveline Nüesch, Paul Dieppe et al. BMJ
  14. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study (2010)
    Eveline Nüesch, Sven Trelle et al. BMJ
  15. Predictors of Permanent Pacemaker Implantation in Patients With Severe Aortic Stenosis Undergoing TAVR (2014)
    George C.M. Siontis, Peter Jüni et al. Journal of the American College of Cardiology
  16. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial (2008)
    Stephan Windecker, Patrick W. Serruys et al. The Lancet
  17. Viscosupplementation for Osteoarthritis of the Knee (2012)
    Anne WS Rutjes, Peter Jüni et al. Annals of Internal Medicine
  18. Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease (2019)
    Subodh Verma, C. David Mazer et al. Circulation
  19. Intra-articular corticosteroid for knee osteoarthritis (2015)
    Peter Jüni, Roman Hari et al. Cochrane Database of Systematic Reviews
  20. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease (2016)
    Giuseppe Ferrante, Sunil V. Rao et al. JACC: Cardiovascular Interventions
  21. The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability (2018)
    Juhani Knuuti, H Ballo et al. European Heart Journal
  22. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial (2018)
    Ewan C. Goligher, George Tomlinson et al. JAMA
  23. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis (2019)
    George C.M. Siontis, Pavel Overtchouk et al. European Heart Journal
  24. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis (2021)
    Bruno R. da Costa, Tiago Pereira et al. BMJ
  25. 2021 ESC/EACTS Guidelines for the management of valvular heart disease (2022)
    Alec Vahanian, Friedhelm Beyersdorf et al. EuroIntervention
  26. Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation (2025)
    Tobias Reichlin, Thomas Kueffer et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 214 standout
Sub-graph 1 of 16

Citing Papers

Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
2021 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
8 intermediate papers

Works of Peter Jüni being referenced

Abolishing Mammography Screening Programs? A View from the Swiss Medical Board
2014
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Peter Jüni 20381 16220 5283 9362 416 63.1k
P.J. Devereaux 23695 16224 4262 10906 395 91.9k
George A. Wells 17537 13766 4238 7480 864 86.7k
Jonathan J Deeks 18953 8570 4618 11118 346 90.3k
Simon G. Thompson 16157 14663 2996 14138 217 88.5k
Jan P. Vandenbroucke 21047 12836 3436 12248 439 107.2k
Christopher H. Schmid 9790 10109 2276 7122 392 60.9k
Jonathan A C Sterne 12776 7358 2198 8366 380 80.4k
Andrew D Oxman 17864 8787 2515 11315 282 102.0k
M. Hassan Murad 23034 9096 2899 15504 955 98.8k
Erik von Elm 17890 8950 2511 10037 130 86.0k

All Works

Loading papers...

Rankless by CCL
2026